Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 1.47M | $38.0M | 12.53% | -- | 2026-06-30 |
| Boxer Capital Management, LLC | 1.11M | $26.0M | 9.41% | +339.4K | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 683.1K | $17.0M | 5.81% | -48.1K | 2026-06-30 |
| Point72 Asset Management, L.P. | 664.3K | $17.0M | 5.65% | -- | 2026-06-30 |
| Venrock Adviser, LLC | 632.9K | $16.0M | 5.38% | -- | 2026-06-30 |
| STEMPOINT CAPITAL LP | 602.8K | $13.0M | 5.13% | +406.8K | 2026-06-30 |
| PERCEPTIVE ADVISORS LLC | 504.0K | $13.0M | 4.29% | +274.6K | 2026-06-30 |
| Spruce Street Capital LP | 432.0K | $11.0M | 3.68% | -- | 2026-06-30 |
| BlackRock, Inc. | 394.9K | $10.0M | 3.36% | +367.0K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 392.6K | $10.0M | 3.34% | +223.5K | 2026-06-30 |
